dc.contributor.advisor | Abell, Troy | |
dc.contributor.author | Cooper, Jacob | |
dc.contributor.other | Baylor University. | en_US |
dc.contributor.other | Lisa Baker | en_US |
dc.contributor.other | Michael Carmichael | en_US |
dc.date.accessioned | 2012-05-07T21:48:59Z | |
dc.date.available | 2012-05-07T21:48:59Z | |
dc.date.copyright | 2012 | |
dc.date.issued | 2012-05-07 | |
dc.identifier.uri | http://hdl.handle.net/2104/8392 | |
dc.description.abstract | Coronary artery bypass grafting (CABG) surgery is one of the most common
operations performed in the United States. Despite the frequency of this operation,
however, it is estimated that surgical site infections (SSIs) occur with a cumulative
incidence between 0.5%-7% among CABG patients. In a time of increasing pressure for
health care to improve in quality, hospitals must prevent such infections or risk being
required to pay for the expenses incurred to treat those infections that arise. Autologous
Platelet Gel (APG) has presented itself as an effective method by which to prevent SSIs
through the escalation of the immunological response and the growth of new tissue. This
decision analysis aims to answer the clinical question: Should Autologous Platelet Gel be
used in Coronary Artery Bypass Grafting procedures along with the current standard of
care (SOC)? A decision analytic model was used to determine the total expected mortality
that is produced from the use of the standard of care (SOC) alone and the SOC along with
APG, giving respect to (a) severity of the SSI; (b) development of deep SSI from a
superficial SSI; (c) surgical revision of the SSI; and (d) the cause of mortality. | en_US |
dc.language.iso | en_US | en_US |
dc.rights | Baylor University projects are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. Contact libraryquestions@baylor.edu for inquiries about permission. | en_US |
dc.subject | Autologous platelet gel. | en_US |
dc.subject | Platelet gel. | en_US |
dc.subject | Platelet rich plasma. | en_US |
dc.subject | Formal decision analysis. | en_US |
dc.subject | Decision analytics. | en_US |
dc.subject | Decision theory. | en_US |
dc.subject | Comparative effectiveness. | en_US |
dc.subject | Coronary artery bypass grafting. | en_US |
dc.subject | Decision analysis. | en_US |
dc.subject | Cardiovascular surgery. | en_US |
dc.subject | Surgical site infections. | en_US |
dc.subject | Nosocomial infections. | en_US |
dc.subject | Expected mortality. | en_US |
dc.title | Comparative Effectiveness of Autologous Platelet Gel in Coronary Artery Bypass Grafting Surgery: A Formal Decision Analysis | en_US |
dc.type | Thesis | en_US |
dc.rights.accessrights | Worldwide access. | en_US |
dc.rights.accessrights | Access changed 12/15/14. | |
dc.contributor.department | Economics | en_US |
dc.contributor.schools | honors college | en_US |